May 15, 2019
Powles T et al. Nature Medicine 2019;25:1706–1714.
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
You might also be interested by
Infographics
Advance Your Cell Therapy - with our cross-platform capabilities
November 5, 2021
Histopathology
More info